×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Jeffrey V. Poulton

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ALNYALNYLAM PHARMACEUTICALS, INC.Jeffrey V. PoultonEVP, Chief Financial OfficerAug 18, 2025Sale$453.272,2741,030,72752,332Aug 19, 2025, 05:27 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Jeffrey V. PoultonEVP, Chief Financial OfficerMar 03, 2025Sale$243.781,264308,14148,665Mar 05, 2025, 04:21 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Jeffrey V. PoultonEVP, Chief Financial OfficerFeb 14, 2025Sale$255.17967246,75033,536Feb 18, 2025, 04:47 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Jeffrey V. PoultonEVP, Chief Financial OfficerNov 26, 2024Sale$250.981,682422,14432,296Nov 27, 2024, 05:21 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Jeffrey V. PoultonEVP, Chief Financial OfficerJun 25, 2024Sale$231.001,605370,74730,438Jun 26, 2024, 04:26 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Jeffrey V. PoultonEVP, Chief Financial OfficerFeb 28, 2024Sale$155.3057489,14519,805Feb 29, 2024, 04:18 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Jeffrey V. PoultonEVP, Chief Financial OfficerFeb 27, 2024Option/RSU Exercise-1,908-20,052Feb 29, 2024, 04:18 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Jeffrey V. PoultonEVP, Chief Financial OfficerFeb 16, 2024Sale$148.061,007149,09918,782Feb 20, 2024, 04:08 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Jeffrey V. PoultonEVP, Chief Financial OfficerAug 04, 2023Sale$185.853,460643,03718,675Aug 07, 2023, 06:05 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Jeffrey V. PoultonEVP, Chief Financial OfficerApr 27, 2023Sale$194.59977190,11312,602Apr 28, 2023, 05:55 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Jeffrey V. PoultonEVP, Chief Financial OfficerAug 04, 2022Tax Payment (Shares)$191.695,054968,8249,887Aug 05, 2022, 04:14 PM